Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy

Int J Dermatol. 1993 Nov;32(11):830-1. doi: 10.1111/j.1365-4362.1993.tb02779.x.

Authors

M Lebwohl¹, E Peets, V Chen

Affiliation

¹ Department of Dermatology, Mount Sinai Medical Center, New York, NY 10029-6574.

PMID: 8270349
DOI: 10.1111/j.1365-4362.1993.tb02779.x

No abstract available

MeSH terms

Administration, Cutaneous
Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / therapeutic use*
Dermatitis, Atopic / drug therapy*
Facial Dermatoses / drug therapy*
Follow-Up Studies
Glucocorticoids
Humans
Intertrigo / drug therapy*
Mometasone Furoate
Ointments
Pregnadienediols / administration & dosage
Pregnadienediols / therapeutic use*
Psoriasis / drug therapy*
Safety
Time Factors

Substances

Anti-Inflammatory Agents
Glucocorticoids
Ointments
Pregnadienediols
Mometasone Furoate